Clinical Trial Update: Three-pronged Centralized Molecular Analysis to Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer

View source ↗

Summary

This completed trial evaluates a three-pronged centralized molecular analysis to improve detection of NTRK1/2/3 fusions in thyroid cancer, aiming to enhance dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Thyroid Cancer | Status: COMPLETED